# Machine Representation Implementation Completion Audit v0

Stewarded by [frg.earth](https://frg.earth/).

- disease program: `multiple-myeloma`
- artifact id: `machine-representation-implementation-completion-audit-v0`
- ORP item: `machine-representation-implementation-completion-audit-v0`
- named phase: `myeloma-machine-representation-implementation-v0`
- audit status: public-safe machine-representation implementation phase
  complete; next work is human-gated
- claim level: open-question
- clinical boundary: research-use-only, not medical advice
- data boundary: public artifacts and synthetic fixtures only; no real case
  data, identifiers, raw records, person-linked dates, private correspondence,
  private reviewer comments, or patient-specific outputs
- completion boundary: public-safe machine-representation implementation
  phase only; not scientific completion, clinical completion, expert-review
  completion, private-lab readiness, publication approval, release approval,
  model validation, or a cure claim
- last reviewed: `2026-04-18`

## Purpose

This audit inspects the human-selected
`myeloma-machine-representation-implementation-v0` phase after the state
schema, synthetic fixture, output wrapper, validator rule map, source
extraction table, source-gap task queue, and source-gap issue draft packet.

It decides whether the current public-safe autonomous phase is complete,
safely blocked, or ready for another public-safe adjacent item.

It does not review private lab records, real cases, expert correspondence,
model weights, model outputs, clinical decisions, sponsor decisions, legal
decisions, regulatory decisions, publication decisions, or release decisions.

## Audit Decision

Decision: `machine-representation-phase-complete-human-gated`.

Meaning:

- the current `myeloma-machine-representation-implementation-v0` public-safe
  queue has a first useful schema, fixture, boundary wrapper, rule map,
  source extraction table, source-gap task queue, issue draft packet, and this
  audit
- the remaining work is not a public autonomous implementation task until a
  human selects a new named phase or clears a named gate
- ORP should record a blocked next item rather than inventing model code,
  executable validation, source ranking, or dashboard work by momentum

This decision does not mean that multiple myeloma research is complete, that
any artifact is expert-reviewed, that any artifact is clinical-review-ready,
that any model can be trained or deployed, that any case can be processed
publicly, that publication is authorized, or that a cure or vaccine has been
found.

## Inputs Audited

| Input | Audit Use |
| --- | --- |
| [Case-To-Cure Adaptive Master Plan v0](case-to-cure-adaptive-master-plan-v0.md) | Canonical durable loop and phase definition. |
| [Myeloma Machine Representation Stack v0](machine-representation-stack-v0.md) | Architecture intent and public-safety boundary. |
| [Myeloma State Object Schema v0](../../schemas/myeloma-state-object-schema-v0.md) | State-object field families, source context, review status, missingness, and blocked output rules. |
| [Synthetic Myeloma State Fixture v0](../../examples/synthetic-myeloma-state-fixture-v0.json) | Synthetic-only scenario coverage for complete multimodal, missing RNA, missing single-cell, and private-source-blocked examples. |
| [Model Output Boundary Wrapper v0](model-output-boundary-wrapper-v0.md) | Refusal and uncertainty rules for progression, response, MRD, and resistance head placeholders. |
| [Myeloma State Validator Rule Map v0](myeloma-state-validator-rule-map-v0.md) | Fail-closed public checks and synthetic coverage mapping. |
| [Machine Representation Source Extraction v0](machine-representation-source-extraction-v0.md) | Architecture claims, public source IDs, source-context gaps, uncertainty, review status, and task seeds. |
| [Machine Representation Source-Gap Task Queue v0](public-tasks/machine-representation-source-gap-task-queue-v0.md) | Contribution-ready public task routing for unresolved source and review gaps. |
| [Machine Representation Source-Gap Issue Draft Packet v0](public-tasks/issue-drafts/machine-representation-source-gap-issue-draft-packet-v0.md) | Human-reviewable issue draft text for the ready source-gap tasks. |
| [Public Inventory v0](public-inventory-v0.md) | Current artifact surface, readiness answers, and navigation map. |
| [Public Artifact Catalog v0](../../artifacts/public-artifact-catalog-v0.md) | Metadata-backed artifact coverage and navigation. |
| [ORP Frontier State](../../orp/frontier/state.json) | Live active phase before the audit. |
| [ORP Additional Items](../../orp/frontier/additional-items.json) | Active queue statuses and next-state handoff. |
| [Public Safety](../../governance/PUBLIC_SAFETY.md) | Repository-wide clinical and data-safety constraints. |

## Completion Matrix

| Public-Safe Requirement | Audit Status | Public Evidence | Residual Boundary |
| --- | --- | --- | --- |
| State object schema exists with source context, uncertainty, missingness, review status, and blocked output fields. | Complete. | [Myeloma State Object Schema v0](../../schemas/myeloma-state-object-schema-v0.md). | Not executable normalization; no real case acceptance. |
| Synthetic fixture exercises key schema scenarios without patient-like values. | Complete. | [Synthetic Myeloma State Fixture v0](../../examples/synthetic-myeloma-state-fixture-v0.json). | Synthetic examples do not authorize case intake or inference. |
| Model output boundaries refuse prediction-head behavior. | Complete. | [Model Output Boundary Wrapper v0](model-output-boundary-wrapper-v0.md). | No model weights, scores, probabilities, recommendations, or rankings. |
| Validator rules are mapped before any executable validator exists. | Complete. | [Myeloma State Validator Rule Map v0](myeloma-state-validator-rule-map-v0.md). | Not a validator implementation and not a real-case validator. |
| Machine-representation architecture claims are source-scoped. | Complete. | [Machine Representation Source Extraction v0](machine-representation-source-extraction-v0.md). | Source-context gaps and expert-review-needed labels remain visible. |
| Source-context gaps are converted into public tasks. | Complete. | [Machine Representation Source-Gap Task Queue v0](public-tasks/machine-representation-source-gap-task-queue-v0.md). | Tasks do not rank sources, evidence, mechanisms, or options. |
| Ready tasks have human-reviewable issue draft text. | Complete. | [Machine Representation Source-Gap Issue Draft Packet v0](public-tasks/issue-drafts/machine-representation-source-gap-issue-draft-packet-v0.md). | Drafts do not open issues, send outreach, request private material, or authorize publication. |
| Navigation and catalog coverage exist. | Complete after this audit is cataloged and linked. | This audit, metadata, public catalog, README, inventory, and ORP updates. | Re-run validation before release or future edits. |
| Remaining work is explicitly gated. | Complete for this named phase. | Human-gate table below and ORP blocked next item. | Gates remain closed until a qualified human or future named phase resolves them. |

## Remaining Human Gates

| Gate Class | What It Covers | Why It Blocks Autonomous Public Work |
| --- | --- | --- |
| `expert-review-needed` | Whether schema fields, source-extraction rows, issue draft asks, and refusal language are scientifically appropriate. | Public artifacts cannot substitute for expert validation or copy private expert correspondence. |
| `private-lab-needed` | Any real case intake, private records, normalized case-state objects, private evidence packets, or private model-ready data. | Public repo cannot receive, process, store, summarize, or expose real case material. |
| `clinical-team-needed` | Diagnosis, prognosis, treatment, trial, expanded-access, monitoring, urgency, eligibility, or action-path decisions. | Public artifacts cannot provide clinical guidance or patient-specific interpretation. |
| `model-governance-needed` | Any future executable validator, model training, calibration, benchmarking, deployment, or model-output review. | This phase intentionally stops at public schema, fixture, rules, and refusal boundaries. |
| `legal-needed` | Privacy basis, de-identification sufficiency, consent language, retention policy, data rights, and release constraints. | Autonomous public work cannot make legal or privacy determinations. |
| `regulatory-needed` | Institutional, ethics, sponsor, site, regulated-tool, or clinical-research pathway decisions. | These decisions require accountable human or institutional review. |
| `publication-gate-needed` | Any public case-derived learning, aggregate update, claim release, case report, or external publication. | Public release requires human authorization and review. |
| `human-review-needed` | Protected-branch review, new named phase selection, issue opening, publication readiness, or maintainer approval. | ORP should not invent the next phase without human direction once this phase is closed. |

## Not Selected As Next Autonomous Work

This audit does not select:

- real case intake, public case upload, private workspace implementation, or
  private-lab data normalization
- executable state-object validator implementation, model training, model
  benchmarking, calibration, dashboarding, or deployment
- model output generation, progression risk, response probability, MRD
  interpretation, resistance attribution, actionability, or option ranking
- source ranking, evidence ranking, mechanism ranking, target ranking, product
  comparison, therapy comparison, or trial matching
- autonomous GitHub issue creation, expert outreach, private-response intake,
  or publication of unpublished correspondence
- protected-branch release, external publication, sponsor or site contact,
  legal review, regulatory review, clinical review, or treating-team decisions

## What This Step Revealed

The machine-representation implementation phase has reached a useful public
substrate: it can describe synthetic state objects, missingness, uncertainty,
blocked prediction heads, fail-closed checks, source-context gaps, public tasks,
and issue-facing source-gap asks without creating a public intake path or model
behavior.

The next useful action is not another autonomous machine-representation
implementation artifact. The next action is a human gate: either choose a new
named public-safe phase or clear one of the named expert, private-lab,
clinical, model-governance, legal, regulatory, publication, or human-review
gates.

## Handoff State

`machine-representation-implementation-completion-audit-v0` is complete after
this artifact is cataloged, navigation is wired, ORP records the blocked next
item, and validation passes.

ORP should activate:

`machine-representation-public-scope-human-gate-blocker-v0`

That blocked item means no further autonomous public-safe
machine-representation implementation item is ready without human selection of
a new phase or human clearance of a named gate.

## Public Safety Check

- No patient-identifying data.
- No real case data.
- No private records, raw records, images, notes, exact person-linked dates,
  raw assay values, therapy histories, molecular reports, pathology reports,
  flow reports, genomics reports, clinician names, site names tied to a
  person, sponsor contacts, contact details, private paths, private prompts,
  private case IDs, or re-identification keys.
- No private correspondence, unpublished expert comments, reviewer
  deliberation, private permission context, private reviewer identities, or
  private contact details.
- No generated biomedical claims, generated case summaries, generated review
  packets, public case reports, case-derived claims, or publication workflow.
- No patient-specific diagnosis, prognosis, treatment, trial, eligibility,
  availability, access, expanded-access, monitoring, urgency,
  safety-management, referral, publication, or candidate-option guidance.
- No patient matching, trial matching, target actionability, source ranking,
  evidence ranking, target ranking, mechanism ranking, product ranking,
  therapy ranking, trial ranking, option ranking, comparison, prioritization,
  recommendation, sequencing, option selection, publication authorization,
  release authorization, or clinical decision.
- No executable validator, model weights, model scores, probability outputs,
  training records, calibration records, benchmark claims, or deployment claim.
- No autonomous outreach, issue creation, publication, pull request, commit, or
  push.
- No cure or vaccine claim.

## Limitations

- This is a public completion audit, not a scientific review.
- This is not expert review.
- This is not clinical review.
- This is not legal review.
- This is not regulatory review.
- This is not privacy review.
- This is not model-governance review.
- This is not publication review.
- This is not release review.
- This does not prove source coverage is comprehensive.
- This does not grade evidence quality.
- This does not validate real case intake, de-identification, normalization,
  evidence retrieval, expert review, multidisciplinary review, model training,
  model validation, public learning extraction, or publication.
- This does not inspect private lab records, private correspondence, expert
  replies, or real case data.
- This does not authorize a live backend, public intake form, upload path,
  private workspace, reviewer workspace, model workspace, or publication
  workflow.
- This does not authorize generated claims, generated packet content,
  generated case summaries, generated publication text, generated model
  outputs, or generated patient-facing outputs.
- This does not authorize diagnosis, prognosis, treatment advice, trial
  advice, eligibility guidance, availability guidance, expanded-access
  guidance, access guidance, monitoring guidance, urgency guidance,
  safety-management guidance, or clinical decisions.
- This does not authorize patient matching, trial matching, target
  actionability, evidence ranking, therapy ranking, product ranking, trial
  ranking, option ranking, comparison, prioritization, recommendation, or
  sequencing.
- This does not authorize outreach, copying private correspondence, publishing
  unpublished reviewer comments, opening issues, or declaring expert
  consensus.
- This does not authorize protected-branch release, external publication,
  public case reporting, or case-derived public learning.
- This does not claim that multiple myeloma has been cured or that a vaccine
  has been found.
